| covalent chromatin modification | GO:0016569 | 163 | 0.457 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.442 | Yeast |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.410 | Yeast |
| histone modification | GO:0016570 | 159 | 0.399 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.380 | |
| chromatin modification | GO:0016568 | 187 | 0.361 | |
| spermatogenesis | GO:0007283 | 284 | 0.348 | |
| regulation of heart rate by chemical signal | GO:0003062 | 4 | 0.343 | |
| male gamete generation | GO:0048232 | 285 | 0.335 | |
| respiratory system development | GO:0060541 | 190 | 0.334 | |
| chromatin organization | GO:0006325 | 206 | 0.332 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.309 | |
| rhythmic process | GO:0048511 | 174 | 0.304 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.290 | |
| muscle tissue development | GO:0060537 | 308 | 0.289 | |
| cholesterol storage | GO:0010878 | 4 | 0.226 | |
| respiratory tube development | GO:0030323 | 167 | 0.223 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.220 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 0.220 | |
| regulation of system process | GO:0044057 | 200 | 0.202 | Human |
| muscle cell development | GO:0055001 | 133 | 0.196 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.194 | |
| regulation of histone modification | GO:0031056 | 56 | 0.193 | |
| myotube differentiation | GO:0014902 | 105 | 0.193 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.189 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.180 | |
| circadian rhythm | GO:0007623 | 114 | 0.175 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.173 | |
| striated muscle cell development | GO:0055002 | 125 | 0.162 | |
| regulation of triglyceride biosynthetic process | GO:0010866 | 10 | 0.154 | |
| heart contraction | GO:0060047 | 93 | 0.152 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.150 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.150 | |
| cell fate commitment | GO:0045165 | 210 | 0.148 | Yeast |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.147 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.143 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.143 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.142 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.141 | |
| lung development | GO:0030324 | 164 | 0.139 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.137 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.137 | |
| digestive system development | GO:0055123 | 200 | 0.136 | |
| regulation of secretion | GO:0051046 | 274 | 0.130 | |
| circulatory system process | GO:0003013 | 197 | 0.129 | |
| positive regulation of protein deacetylation | GO:0090312 | 9 | 0.123 | |
| amine metabolic process | GO:0009308 | 45 | 0.121 | Yeast |
| regulation of organelle organization | GO:0033043 | 289 | 0.120 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.115 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.111 | |
| digestive tract development | GO:0048565 | 190 | 0.108 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.106 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.106 | |
| sterol homeostasis | GO:0055092 | 45 | 0.102 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.101 | |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.099 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.097 | |
| protein deacetylation | GO:0006476 | 32 | 0.096 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.094 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.090 | |
| urogenital system development | GO:0001655 | 261 | 0.089 | |
| myofibril assembly | GO:0030239 | 34 | 0.089 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.088 | |
| epithelial cell development | GO:0002064 | 159 | 0.087 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.085 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.084 | Yeast |
| response to peptide hormone | GO:0043434 | 127 | 0.082 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.082 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.082 | |
| protein deacylation | GO:0035601 | 36 | 0.082 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.081 | |
| blood circulation | GO:0008015 | 195 | 0.081 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.081 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.079 | |
| lipid homeostasis | GO:0055088 | 63 | 0.078 | |
| regulation of protein localization | GO:0032880 | 231 | 0.078 | |
| renal system development | GO:0072001 | 225 | 0.076 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.076 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.076 | |
| gland development | GO:0048732 | 330 | 0.075 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.075 | |
| cellular response to peptide | GO:1901653 | 92 | 0.073 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.073 | Yeast |
| positive regulation of chromatin modification | GO:1903310 | 28 | 0.073 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.072 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.070 | |
| triglyceride metabolic process | GO:0006641 | 51 | 0.070 | |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.070 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.070 | Yeast |
| t cell activation | GO:0042110 | 289 | 0.069 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.068 | |
| response to peptide | GO:1901652 | 136 | 0.068 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.068 | |
| endocytosis | GO:0006897 | 168 | 0.066 | |
| stem cell differentiation | GO:0048863 | 268 | 0.066 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.066 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.065 | |
| heart process | GO:0003015 | 94 | 0.065 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.064 | |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.064 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.063 | Yeast |
| positive regulation of histone modification | GO:0031058 | 28 | 0.063 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.062 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.062 | |
| synapse organization | GO:0050808 | 125 | 0.061 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.061 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.060 | |
| sterol transport | GO:0015918 | 38 | 0.060 | |
| telencephalon development | GO:0021537 | 186 | 0.059 | |
| negative regulation of sterol transport | GO:0032372 | 4 | 0.059 | |
| mesoderm formation | GO:0001707 | 62 | 0.059 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.058 | |
| lipid transport | GO:0006869 | 98 | 0.058 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.058 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.057 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.057 | |
| epithelial cell morphogenesis | GO:0003382 | 41 | 0.057 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.057 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.057 | |
| regulation of cholesterol biosynthetic process | GO:0045540 | 8 | 0.057 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.056 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.056 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.055 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.055 | |
| maintenance of location | GO:0051235 | 89 | 0.055 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.055 | |
| histone deacetylation | GO:0016575 | 26 | 0.054 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.054 | |
| spermatid differentiation | GO:0048515 | 115 | 0.054 | |
| cholesterol transport | GO:0030301 | 38 | 0.053 | |
| protein localization to organelle | GO:0033365 | 185 | 0.053 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.053 | Yeast |
| ossification | GO:0001503 | 216 | 0.053 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.052 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.052 | |
| response to insulin | GO:0032868 | 100 | 0.052 | |
| compound eye development | GO:0048749 | 1 | 0.052 | |
| cell adhesion | GO:0007155 | 329 | 0.052 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.051 | |
| response to low density lipoprotein particle | GO:0055098 | 2 | 0.051 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.050 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.050 | Human |
| regulation of peptide transport | GO:0090087 | 91 | 0.050 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.050 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.050 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.049 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.048 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.048 | |
| activation of immune response | GO:0002253 | 138 | 0.048 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.047 | |
| gastrulation | GO:0007369 | 116 | 0.047 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.047 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.046 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.046 | |
| muscle fiber development | GO:0048747 | 76 | 0.046 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.046 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.046 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.045 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.045 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.045 | |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.045 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.044 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.044 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.043 | |
| regulation of ossification | GO:0030278 | 112 | 0.043 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.043 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.043 | |
| blastocyst development | GO:0001824 | 80 | 0.043 | Human |
| cardiocyte differentiation | GO:0035051 | 87 | 0.042 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.042 | |
| positive regulation of steroid biosynthetic process | GO:0010893 | 4 | 0.042 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.042 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.042 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.042 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.041 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.041 | |
| embryonic placenta development | GO:0001892 | 98 | 0.040 | |
| protein maturation | GO:0051604 | 176 | 0.040 | |
| cytokine production | GO:0001816 | 319 | 0.039 | |
| heart morphogenesis | GO:0003007 | 178 | 0.039 | |
| lateral inhibition | GO:0046331 | 1 | 0.038 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.038 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.038 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.038 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.037 | |
| liver development | GO:0001889 | 66 | 0.037 | |
| neuron death | GO:0070997 | 154 | 0.037 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.037 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.037 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.037 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.037 | |
| histone acetylation | GO:0016573 | 41 | 0.036 | |
| mesoderm development | GO:0007498 | 100 | 0.036 | |
| lipid localization | GO:0010876 | 126 | 0.036 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.036 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.036 | Yeast |
| cellular protein catabolic process | GO:0044257 | 155 | 0.036 | |
| dephosphorylation | GO:0016311 | 129 | 0.036 | |
| positive regulation of cholesterol biosynthetic process | GO:0045542 | 3 | 0.036 | |
| lipid storage | GO:0019915 | 36 | 0.036 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.035 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.035 | |
| positive regulation of cholesterol metabolic process | GO:0090205 | 3 | 0.035 | |
| response to inorganic substance | GO:0010035 | 96 | 0.034 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.034 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.034 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.034 | |
| axonogenesis | GO:0007409 | 274 | 0.034 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.034 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.034 | |
| fat cell differentiation | GO:0045444 | 160 | 0.034 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.034 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.034 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.034 | |
| cell fate specification | GO:0001708 | 72 | 0.034 | |
| single organism nuclear import | GO:1902593 | 95 | 0.034 | |
| regulation of protein processing | GO:0070613 | 96 | 0.034 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.033 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.033 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.033 | |
| peptide transport | GO:0015833 | 133 | 0.033 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.033 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.033 | |
| t cell differentiation | GO:0030217 | 174 | 0.033 | |
| regulation of steroid biosynthetic process | GO:0050810 | 26 | 0.033 | |
| nephron development | GO:0072006 | 109 | 0.033 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.033 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.033 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.032 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.032 | |
| positive regulation of lipid biosynthetic process | GO:0046889 | 18 | 0.032 | |
| ear development | GO:0043583 | 200 | 0.032 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.032 | |
| organelle assembly | GO:0070925 | 177 | 0.032 | |
| insulin secretion | GO:0030073 | 89 | 0.031 | |
| regulation of cholesterol storage | GO:0010885 | 4 | 0.031 | |
| protein catabolic process | GO:0030163 | 221 | 0.031 | Worm |
| spermatid development | GO:0007286 | 108 | 0.031 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.031 | Yeast |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.031 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.030 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.030 | Yeast |
| regulation of defense response | GO:0031347 | 233 | 0.030 | |
| hormone secretion | GO:0046879 | 128 | 0.030 | |
| dendrite development | GO:0016358 | 115 | 0.030 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.030 | |
| stem cell development | GO:0048864 | 219 | 0.030 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.030 | |
| response to drug | GO:0042493 | 75 | 0.030 | |
| protein targeting | GO:0006605 | 143 | 0.030 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.030 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.030 | Worm |
| locomotory behavior | GO:0007626 | 195 | 0.029 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.029 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.029 | |
| nuclear import | GO:0051170 | 95 | 0.029 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.029 | Yeast |
| inner ear morphogenesis | GO:0042472 | 101 | 0.029 | |
| gonad development | GO:0008406 | 141 | 0.028 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.028 | |
| regulation of neuron death | GO:1901214 | 134 | 0.028 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.028 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.028 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.028 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.028 | |
| cellular response to nutrient levels | GO:0031669 | 64 | 0.028 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.028 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.028 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.028 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.028 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.028 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.027 | |
| response to oxidative stress | GO:0006979 | 123 | 0.027 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.027 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.027 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.027 | |
| cell growth | GO:0016049 | 130 | 0.027 | |
| mapk cascade | GO:0000165 | 281 | 0.027 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.027 | |
| developmental maturation | GO:0021700 | 193 | 0.027 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.027 | |
| cholesterol efflux | GO:0033344 | 24 | 0.027 | |
| muscle system process | GO:0003012 | 141 | 0.027 | Human |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.027 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.027 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.026 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.026 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.026 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.026 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.026 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.026 | |
| regulation of heart rate | GO:0002027 | 36 | 0.026 | |
| nuclear transport | GO:0051169 | 139 | 0.026 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.025 | |
| response to monosaccharide | GO:0034284 | 67 | 0.025 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.025 | |
| artery development | GO:0060840 | 53 | 0.025 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.025 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.025 | |
| regulation of sterol transport | GO:0032371 | 17 | 0.025 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.025 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.025 | |
| mesodermal cell migration | GO:0008078 | 4 | 0.025 | |
| intracellular protein transport | GO:0006886 | 204 | 0.025 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.025 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.025 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.025 | |
| response to metal ion | GO:0010038 | 47 | 0.024 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.024 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.024 | |
| negative regulation of cholesterol efflux | GO:0090370 | 4 | 0.024 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.024 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.024 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.024 | |
| myosin filament assembly | GO:0031034 | 2 | 0.024 | |
| response to starvation | GO:0042594 | 65 | 0.024 | |
| peptide secretion | GO:0002790 | 114 | 0.024 | |
| regulation of lipid storage | GO:0010883 | 20 | 0.024 | |
| synapse assembly | GO:0007416 | 56 | 0.024 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.024 | |
| kidney development | GO:0001822 | 213 | 0.024 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.024 | |
| ear morphogenesis | GO:0042471 | 118 | 0.023 | |
| kidney epithelium development | GO:0072073 | 121 | 0.023 | |
| negative regulation of insulin secretion | GO:0046676 | 14 | 0.023 | |
| response to growth factor | GO:0070848 | 198 | 0.023 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.023 | |
| cardiac muscle contraction | GO:0060048 | 32 | 0.023 | |
| positive regulation of triglyceride biosynthetic process | GO:0010867 | 6 | 0.023 | |
| t cell proliferation | GO:0042098 | 120 | 0.023 | |
| synaptic transmission | GO:0007268 | 329 | 0.023 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.023 | Yeast |
| protein import into nucleus translocation | GO:0000060 | 12 | 0.023 | |
| regulation of cell motility | GO:2000145 | 236 | 0.023 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.023 | |
| regulation of cell migration | GO:0030334 | 219 | 0.023 | |
| myosin filament organization | GO:0031033 | 3 | 0.023 | |
| germ cell development | GO:0007281 | 185 | 0.023 | |
| response to nutrient levels | GO:0031667 | 109 | 0.023 | |
| rna processing | GO:0006396 | 105 | 0.023 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.023 | |
| regulation of steroid metabolic process | GO:0019218 | 39 | 0.022 | |
| regulation of cell activation | GO:0050865 | 289 | 0.022 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.022 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.022 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.022 | |
| diencephalon development | GO:0021536 | 63 | 0.022 | |
| lung cell differentiation | GO:0060479 | 30 | 0.022 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.022 | |
| myotube cell development | GO:0014904 | 60 | 0.022 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.022 | |
| negative regulation of peptide hormone secretion | GO:0090278 | 16 | 0.022 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.022 | |
| metanephros development | GO:0001656 | 79 | 0.022 | |
| cholesterol metabolic process | GO:0008203 | 56 | 0.022 | |
| male sex differentiation | GO:0046661 | 109 | 0.021 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.021 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.021 | |
| regulation of organ growth | GO:0046620 | 61 | 0.021 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.021 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.021 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.021 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.021 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.021 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.021 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.021 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.021 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.021 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.021 | |
| negative regulation of peptide secretion | GO:0002792 | 16 | 0.021 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.021 | |
| female gamete generation | GO:0007292 | 74 | 0.021 | |
| regulation of cell division | GO:0051302 | 76 | 0.020 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.020 | |
| regionalization | GO:0003002 | 337 | 0.020 | |
| epithelial tube formation | GO:0072175 | 130 | 0.020 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.020 | |
| gliogenesis | GO:0042063 | 141 | 0.020 | |
| skin development | GO:0043588 | 220 | 0.020 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.020 | |
| negative regulation of hormone secretion | GO:0046888 | 20 | 0.020 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.020 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.020 | |
| protein import | GO:0017038 | 101 | 0.020 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.020 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.020 | |
| protein import into nucleus | GO:0006606 | 95 | 0.020 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.020 | |
| sensory perception | GO:0007600 | 245 | 0.020 | |
| innate immune response | GO:0045087 | 157 | 0.020 | |
| regulation of cholesterol homeostasis | GO:2000188 | 9 | 0.020 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.020 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.020 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.020 | |
| microtubule based process | GO:0007017 | 236 | 0.020 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.020 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.020 | |
| mitochondrion organization | GO:0007005 | 134 | 0.020 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.020 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.020 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.019 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.019 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.019 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.019 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.019 | |
| organelle fission | GO:0048285 | 170 | 0.019 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.019 | |
| placenta development | GO:0001890 | 140 | 0.019 | |
| muscle contraction | GO:0006936 | 101 | 0.019 | Human |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.019 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.019 | |
| oocyte axis specification | GO:0007309 | 2 | 0.019 | |
| lens morphogenesis in camera type eye | GO:0002089 | 24 | 0.019 | |
| protein processing | GO:0016485 | 163 | 0.019 | |
| protein ubiquitination | GO:0016567 | 171 | 0.019 | |
| cardiac chamber development | GO:0003205 | 108 | 0.019 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.019 | |
| male sex determination | GO:0030238 | 14 | 0.019 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.018 | |
| neuromuscular process | GO:0050905 | 99 | 0.018 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.018 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.018 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.018 | |
| lung alveolus development | GO:0048286 | 45 | 0.018 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.018 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.018 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.018 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.018 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.018 | |
| positive regulation of histone deacetylation | GO:0031065 | 7 | 0.018 | |
| positive regulation of secondary heart field cardioblast proliferation | GO:0072513 | 4 | 0.018 | |
| positive regulation of steroid metabolic process | GO:0045940 | 5 | 0.017 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.017 | |
| steroid metabolic process | GO:0008202 | 119 | 0.017 | |
| chemotaxis | GO:0006935 | 247 | 0.017 | |
| negative regulation of muscle tissue development | GO:1901862 | 20 | 0.017 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.017 | |
| positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation | GO:2000721 | 2 | 0.017 | |
| renal tubule development | GO:0061326 | 87 | 0.017 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.017 | |
| regulation of protein transport | GO:0051223 | 163 | 0.017 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.017 | |
| natural killer cell activation | GO:0030101 | 44 | 0.017 | |
| nk t cell proliferation | GO:0001866 | 2 | 0.017 | |
| nephron tubule development | GO:0072080 | 84 | 0.017 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.017 | Yeast |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.017 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.016 | |
| mesenchyme development | GO:0060485 | 152 | 0.016 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.016 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.016 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.016 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.016 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.016 | |
| specification of organ identity | GO:0010092 | 30 | 0.016 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.016 | |
| cell division | GO:0051301 | 120 | 0.016 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.016 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.016 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.016 | |
| lens fiber cell apoptotic process | GO:1990086 | 4 | 0.016 | |
| nerve development | GO:0021675 | 67 | 0.016 | |
| regulation of muscle system process | GO:0090257 | 80 | 0.016 | Human |
| response to organic cyclic compound | GO:0014070 | 198 | 0.016 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.016 | |
| negative regulation of cysteine type endopeptidase activity | GO:2000117 | 22 | 0.016 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.016 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.016 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.016 | |
| sterol biosynthetic process | GO:0016126 | 17 | 0.016 | |
| actin filament organization | GO:0007015 | 113 | 0.016 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.016 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.016 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.015 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.015 | |
| cellular response to lipid | GO:0071396 | 145 | 0.015 | |
| oxidation reduction process | GO:0055114 | 342 | 0.015 | |
| phagocytosis | GO:0006909 | 66 | 0.015 | |
| embryonic digestive tract development | GO:0048566 | 27 | 0.015 | |
| cholesterol biosynthetic process | GO:0006695 | 15 | 0.015 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.015 | |
| tube formation | GO:0035148 | 140 | 0.015 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.015 | |